Cannabidiol for Reduction of Brain Neuroinflammation
NCT05066308
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
80
Enrollment
OTHER
Sponsor class
Conditions
Back Pain
Depressive Symptoms
Interventions
DRUG:
CBD
OTHER:
Placebo
Sponsor
Massachusetts General Hospital